Emerging Roles of Transforming Growth Factor β Signaling in Diabetic Retinopathy

Sarah E. Wheeler, Nam Y. Lee

Research output: Contribution to journalReview articlepeer-review

26 Scopus citations


Diabetic retinopathy (DR) is a serious complication of diabetes mellitus affecting about one third of diabetic adults. Despite its prevalence, treatment options are limited and often implemented only in the later stages of the disease. To date, the pathogenesis of DR has been extensively characterized in the context of elevated glucose, insulin, and VEGF signaling, although a growing number of other growth factors and molecules, including transforming growth factor β (TGF-β) are being recognized as important contributors and/or therapeutic targets. Here, we review the complex roles of TGF-β signaling in DR pathogenesis and progression. J. Cell. Physiol. 232: 486–489, 2017.

Original languageEnglish (US)
Pages (from-to)486-489
Number of pages4
JournalJournal of Cellular Physiology
Issue number3
StatePublished - Mar 1 2017

ASJC Scopus subject areas

  • Physiology
  • Clinical Biochemistry
  • Cell Biology


Dive into the research topics of 'Emerging Roles of Transforming Growth Factor β Signaling in Diabetic Retinopathy'. Together they form a unique fingerprint.

Cite this